Patents by Inventor Curtis A. Machida

Curtis A. Machida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080057531
    Abstract: Provided are systems, kits, and methods for the detection and identification of cariogenic bacteria in dental plaque and for assessing the risk in a patient of development dental caries based upon the presence of cariogenic bacteria.
    Type: Application
    Filed: August 7, 2007
    Publication date: March 6, 2008
    Inventors: Curtis Machida, Tom Maier
  • Patent number: 7022816
    Abstract: A mammalian D2 dopamine receptor gene has been cloned. Thus, DNA sequences encoding all or a part of the dopamine receptor are provided, as well as the corresponding polypeptide sequences and methods for producing the same both synthetically and via expression of a corresponding sequence from a host transformed with a suitable vector carrying the corresponding DNA sequence. The various structural information provided by this invention enables the preparation of labeled or unlabeled immunospecific species, particularly antibodies, as well as nucleic acid probes labeled in conventional fashion. Pharmaceutical compositions and methods of using various products of this invention are also provided.
    Type: Grant
    Filed: August 21, 2001
    Date of Patent: April 4, 2006
    Assignee: Oregon Health and Science University
    Inventors: Oliver Civelli, James R. Bunzow, David K. Grandy, Curtis A. Machida
  • Publication number: 20030040022
    Abstract: A mammalian D2 dopamine receptor gene has been cloned. Thus, DNA sequences encoding all or a part of the dopamine receptor are provided, as well as the corresponding polypeptide sequences and methods for producing the same both synthetically and via expression of a corresponding sequence from a host transformed with a suitable vector carrying the corresponding DNA sequence. The various structural information provided by this invention enables the preparation of labeled or unlabeled immunospecific species, particularly antibodies, as well as nucleic acid probes labeled in conventional fashion. Pharmaceutical compositions and methods of using various products of this invention are also provided.
    Type: Application
    Filed: January 29, 2002
    Publication date: February 27, 2003
    Applicant: Oregon Health and Sciences University
    Inventors: Olivier Civelli, James R. Bunzow, David K. Grandy, Curtis A. Machida
  • Publication number: 20020123096
    Abstract: A mammalian D2 dopamine receptor gene has been cloned. Thus, DNA sequences encoding all or a part of the dopamine receptor are provided, as well as the corresponding polypeptide sequences and methods for producing the same both synthetically and via expression of a corresponding sequence from a host transformed with a suitable vector carrying the corresponding DNA sequence. The various structural information provided by this invention enables the preparation of labeled or unlabeled immunospecific species, particularly antibodies, as well as nucleic acid probes labeled in conventional fashion. Pharmaceutical compositions and methods of using various products of this invention are also provided.
    Type: Application
    Filed: August 21, 2001
    Publication date: September 5, 2002
    Applicant: Oregon Health Sciences University.
    Inventors: Olivier Civelli, James R. Bunzow, David K. Grandy, Curtis A. Machida
  • Patent number: 6342360
    Abstract: A mammalian D2 dopamine receptor gene has been cloned. Thus, DNA sequences encoding all or a part of the dopamine receptor are provided, as well as the corresponding polypeptide sequences and methods for producing the same both synthetically and via expression of a corresponding sequence from a host transformed with a suitable vector carrying the corresponding DNA sequence. The various structural information provided by this invention enables the preparation of labeled or unlabeled immunospecific species, particularly antibodies, as well as nucleic acid probes labeled in conventional fashion. Pharmaceutical compositions and methods of using various products of this invention are also provided.
    Type: Grant
    Filed: January 27, 1999
    Date of Patent: January 29, 2002
    Assignee: Oregon Health & Science University
    Inventors: Olivier Civelli, James R. Bunzow, David K. Grandy, Curtis A. Machida
  • Patent number: 6277591
    Abstract: A mammalian D2 dopamine receptor gene has been cloned. Thus, DNA sequences encoding all or a part of the dopamine receptor are provided, as well as the corresponding polypeptide sequences and methods for producing the same both synthetically and via expression of a corresponding sequence from a host transformed with a suitable vector carrying the corresponding DNA sequence. The various structural information provided by this invention enables the preparation of labeled or unlabeled immunospecific species, particularly antibodies, as well as nucleic acid probes labeled in conventional fashion. Pharmaceutical compositions and methods of using various products of this invention are also provided.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 21, 2001
    Assignee: Oregon Health Science University
    Inventors: Olivier Civelli, James R. Bunzow, David K. Grandy, Curtis A. Machida
  • Patent number: 5880260
    Abstract: A mammalian D.sub.2 dopamine receptor gene has been cloned. Thus, DNA sequences encoding all or a part of the dopamine receptor are provided, as well as the corresponding polypeptide sequences and methods for producing the same both synthetically and via expression of a corresponding sequence from a host transformed with a suitable vector carrying the corresponding DNA sequence. The various structural information provided by this invention enables the preparation of labeled or unlabeled immunospecific species, particularly antibodies, as well as nucleic acid probes labeled in conventional fashion. Pharmaceutical compositions and methods of using various products of this invention are also provided.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 9, 1999
    Assignee: Oregon Health Sciences University
    Inventors: Olivier Civelli, James R. Bunzow, David K. Grandy, Curtis A. Machida